Similar Articles
1301 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1302 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1303 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1304 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1305 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
1306 Role of innate immunity in the development of hepatocellular carcinoma
1307 Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
1308 Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update
1309 Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified?
1310 Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: The utility of conventional MR imaging
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA